Leukemia inhibitory factor ameliorates experimental anti-GBM Ab glomerulonephritis
- 1 December 1996
- journal article
- Published by Elsevier in Kidney International
- Vol. 50 (6) , 1922-1927
- https://doi.org/10.1038/ki.1996.514
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Passive immunization of mice against D factor blocks lethality and cytokine release during endotoxemia.The Journal of Experimental Medicine, 1993
- Leukemia inhibitory factor/differentiation‐stimulating factor (LIF/D‐factor): Regulation of its production and possible roles in bone metabolismJournal of Cellular Physiology, 1992
- Differentiation factor/leukemia inhibitory factor protection against lethal endotoxemia in mice: synergistic effect with interleukin 1 and tumor necrosis factor.The Journal of Experimental Medicine, 1992
- HILDA/LIF URINARY EXCRETION DURING ACUTE KIDNEY REJECTIONTransplantation, 1992
- Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes.The Journal of Experimental Medicine, 1991
- Clearance and fate of leukemia‐inhibitory factor (LIF) after injection into miceJournal of Cellular Physiology, 1991
- Antiserum against tumor necrosis factor-alpha and a protease inhibitor reduce immune glomerular injuryKidney International, 1991
- The leukemia inhibitory factor (LIF)The International Journal of Cell Cloning, 1991
- Cachectin: More Than a Tumor Necrosis FactorNew England Journal of Medicine, 1987
- Cachectin/tumor necrosis factor stimulates collagenase and prostaglandin E2 production by human synovial cells and dermal fibroblasts.The Journal of Experimental Medicine, 1985